Searchable abstracts of presentations at key conferences in endocrinology

ea0081p738 | Thyroid | ECE2022

Predictors of associated autoimmune diseases in patients with Hashimoto′s thyroiditis.

Ruggeri Rosaria , Trunfio Francesca , Giuffrida Giuseppe , Trimarchi Francesco , Campenni Alfredo , Cannavo Salvatore

Background: Increased rates of autoimmune diseases (ADs) have been reported in association with Hashimoto′s thyroiditis (HT); however, the risk factors for coexisting ADs in HT patients have been poorly investigated.Objective: To evaluate the prevalence and factors associated with AD comorbidities in patients with HT.Materials and Methods: We recruited 687 patients (626 F and 61 M, mean age at diagnosis 39 ± 14.06 yr, F:...

ea0063gp178 | Benign Thyroid Disorders | ECE2019

Cystic fibrosis as a novel cause of thyroxine (l-t4) malabsorption and increased requirement

Giuffrida Giuseppe , Magazzu Giuseppe , Campenni Alfredo , Lucanto Maria Cristina , Trimarchi Francesco , Cannavo Salvatore , Ruggeri Rosaria Maddalena

Background: Cystic fibrosis (CF), a monogenic disease from mutations in the CFTR gene on chromosome 7, causes pancreatic insufficiency and impaired nutrients absorption. Unlike other malabsorption disorders, no data are available in literature on L-T4 absorption in CF. This study analyzed L-T4 absorption and requirement in hypothyroid CF patients.Methods: Ten CF patients (7 F, 3 M; mean age 37 yr), with autoimmune (n=6) or post-thyroidectomy (<e...

ea0063gp239 | Anterior and Posterior Pituitary | ECE2019

Peptide receptor radionuclide therapy (PRRT) in patients with giant aggressive pituitary tumors: experience of an Italian referral center and review of literature

Giuffrida Giuseppe , Ferrau Francesco , Laudicella Riccardo , Cotta Oana Ruxandra , Vento Antonio , Baldari Sergio , Cannavo Salvatore

Background: Pituitary tumours (PT) are generally benign, but they can rarely show an aggressive behaviour, invade surrounding structures and/or grow/recur despite multimodal treatment, making their management extremely challenging. According to the latest guidelines, temozolomide (TMZ) can be an option after failure of standard therapies in aggressive PT, while little data are available on alternative approaches such as peptide receptor radionuclide therapy (PRRT). Herein we r...

ea0081ep702 | Pituitary and Neuroendocrinology | ECE2022

Giant pituitary adenomas in children and adolescents: clinical presentation, management and long-term outcome

Giuffrida Giuseppe , giovinazzo salvatore , Alessi Ylenia , Ragonese Marta , Cotta Oana Ruxandra , Angileri Filippo Flavio , Ferrau Francesco , Cannavo Salvatore

Background: Pituitary adenomas in children/adolescents represent around 3% of all intracranial neoplasms. They are more frequently hormone-secreting lesions, usually diagnosed in early childhood and late adolescence. Female gender is generally prevalent, because of most evident symptoms (i.e., irregular periods, galactorrhea, etc.). Giant pituitary adenomas (GA) very rarely occur in pediatric age, posing frequent challenges in their management.Patients a...

ea0049gp208 | Thyroid 2 | ECE2017

Serum Interleukin-37 (IL-37) levels were increased and correlated with oxidative stress parameters in Hashimoto’s Thyroiditis (HT) patients

Ruggeri Rosaria Maddalena , Vicchio Teresa Manuela , Alibrandi Angela , Giovinazzo Salvatore , Certo Rosaria , Giuffrida Giuseppe , Trimarchi Francesco , Gangemi Sebastiano , Cristani Mariateresa

Background: IL-37, member of the IL-1 family, is a natural suppressor of immune and inflammatory responses. Increased serum IL-37 levels were observed in several autoimmune diseases, including Graves’ disease. No data on TH are available from the literature.Materials and methods: We enrolled 45 euthyroid HT patients (5 M e 40 F, mean age 38.5±12.6) and 50 age- and sex-matched healthy controls. None was on LT-4 therapy. Smokers, subjects with ki...

ea0070aep870 | Thyroid | ECE2020

Dietary pattern and oxidative stress markers in hashimoto’s thyroiditis

Ruggeri Rosaria , Giovinazzo Salvo , Giuffrida Giuseppe , Teresa Vicchio Maria , Teresa Cristani Maria , Alibrandi Angela , Campenni Alfredo , Trimarchi University of Messina Francesco

Objective: Oxidative stress has been implicated in the pathogenesis of several immune-mediated disorders, including autoimmune thyroid disease. Aim of our study was to investigate the relationship between dietary habit and redox homeostasis, in relationship with thyroid autoimmunity.Materials and methods: We enrolled 200 healthy subjects (173 F, mean age 35 ± 12). None of them was under any pharmacological treatment. Exclusion criteria: any infectio...

ea0092ps2-11-01 | Miscellaneous 2 | ETA2023

Temporal pattern of thyroid function changes in patients with cured and not cured adrenocorticotropin (ACTH)-Dependent Hypercortisolism

Paola Giuseppe , Alessi Ylenia , Giovinazzo Salvatore , Giuffrida Giuseppe , Casablanca Rosalinda , Ragonese Marta , Certo Rosaria , Ferrau Francesco , Cannavo Salvatore , Moleti Mariacarla

Context: Chronic hypercortisolism is known to impact the hypothalamus-pituitary-thyroid (HPT) axis, through a disruption of both thyrotropin-releasing-hormone and thyroid-stimulating hormone (TSH) release. These changes, in turn, are responsible for reduced triiodothyronine (T3) and thyroxine (T4) synthesis and secretion, eventually resulting in central hypothyroidism (C-Hypo). However, data on magnitude and timing of recovery of the above abnormalities are still controversial...

ea0081p531 | Adrenal and Cardiovascular Endocrinology | ECE2022

Long-term efficacy and safety of pasireotide in patients with Cushing’s disease: a monocentric experience

Alessi Ylenia , Luisa Torre Maria , Giovinazzo Salvatore , Giuffrida Giuseppe , Giandalia Annalisa , Casablanca Rosalinda , Flavio Angileri Filippo , Ragonese Marta , Ferrau Francesco , Cannavo Salvatore

Pasireotide is the first pituitary-directed approved therapy for Cushing’s disease (CD), effective in reducing UFC >50% in about half of patients, and with a good tolerability profile but associated with a relatively high incidence of hyperglicemia. The aim of this study was to evaluate efficacy and safety of long-term treatment with pasireotide (PAS) in patients with CD. Methods: We retrospectively evaluated 17 consecutive patients (11 females) with CD treated with P...

ea0090p700 | Pituitary and Neuroendocrinology | ECE2023

Grading of pituitary adenomas (PitNets): clinical and prognostic implications in a monocentric series

Giuffrida Giuseppe , Casablanca Rosalinda , Ragonese Marta , Giovinazzo Salvatore , Ruxandra Cotta Oana , Certo Rosaria , Alessi Ylenia , Scordo Marianna , Pizzimenti Cristina , Tuccari Giovanni , Flavio Angileri Filippo , Ferrau Francesco , Cannavo Salvatore

Rationale: Pituitary neuroendocrine tumors (PitNets) are aggressive in 20% of cases, with local invasion, relapse/scarce response to conventional treatment, in the absence of reliable predictive parameters. In 2018, Trouillas et al. proposed a 5-tier prognostic classification, not widely validated yet. In our study we evaluated the outcomes of a PitNets monocentric series in the context of this classification.Materials & Methods: We retrospe...